Suppr超能文献

诊断产毒艰难梭菌:新的置信区间表明培养可提高毒素A/B酶免疫测定的灵敏度并反驳金标准。

Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.

作者信息

Mattner Frauke, Winterfeld Ingo, Mattner Lutz

机构信息

Institut für Hygiene, Universitätsklinikum der privaten Universität Witten-Herdecke, Campus Köln-Merheim, Köln, Germany.

出版信息

Scand J Infect Dis. 2012 Aug;44(8):578-85. doi: 10.3109/00365548.2012.655772. Epub 2012 Mar 11.

Abstract

OBJECTIVE

To scrutinize published sensitivity estimates obtained using questionable gold standards by comparing sensitivities of culturing Clostridium difficile in commercially available media followed by enzyme immunoassay (EIA) toxin A or B detection (culture test) with applying the EIA to stool samples alone (direct test).

METHODS

In 2008, consecutive stool samples were cultured on C. difficile selective culture media: (1) medium I: Clostridium difficile-selective agar (CDSA; Becton Dickinson); (2) medium II: CLO agar (BioMérieux); (3) medium III: C. difficile agar according to Brazier (Oxoid). In addition, a direct test was performed (Ridascreen, r-Biopharm), which was also used to confirm toxin A or B production in the cultured C. difficile. New confidence bounds for sensitivities were applied, without assuming any perfect reference test or any conditional independence of the tests compared.

RESULTS

Of 256 liquid stool samples, 18.4% were diagnosed as positive by at least 1 of the 4 tests; 12.8% were positive with culture medium I, 16.4% with medium II, and 13.6% with medium III, and 10.1% were positive by the direct test. Assuming culture tests to be at least as specific as the direct test yields an upper bound of 61% (upper 95% confidence bound (CB) 81%) for the sensitivity of the direct test. Assuming a prevalence of 15% yields sensitivity gains of the culture tests of at least 18% (lower 95% CB--4%) for medium I, 40% (lower 95% CB 21%) for medium II, and 23% (lower 95% CB 2%) for medium III.

CONCLUSIONS

Published high sensitivities of direct toxin A/B EIAs, up to 96%, and the correctness of the cytotoxicity test assumed for their estimation are doubtful. With culture medium II, sensitivity gains of at least about 20% are obtainable. Direct toxin A/B EIAs alone are insufficiently sensitive for the clinical diagnosis of C. difficile infections.

摘要

目的

通过比较在市售培养基中培养艰难梭菌后进行酶免疫测定(EIA)毒素A或B检测(培养试验)与仅将EIA应用于粪便样本(直接试验)的敏感性,来仔细审查使用有问题的金标准获得的已发表敏感性估计值。

方法

2008年,连续的粪便样本在艰难梭菌选择性培养基上培养:(1)培养基I:艰难梭菌选择性琼脂(CDSA;Becton Dickinson);(2)培养基II:CLO琼脂(BioMérieux);(3)培养基III:根据Brazier方法制备的艰难梭菌琼脂(Oxoid)。此外,进行了直接试验(Ridascreen,r - Biopharm),该试验也用于确认培养的艰难梭菌中毒素A或B的产生。应用了新的敏感性置信区间,且未假定任何完美的参考试验或所比较试验的任何条件独立性。

结果

在256份液体粪便样本中,4种试验中至少有1种诊断为阳性的占18.4%;培养基I阳性率为12.8%,培养基II为16.4%,培养基III为13.6%,直接试验阳性率为10.1%。假设培养试验至少与直接试验一样具有特异性,则直接试验敏感性的上限为61%(95%置信区间上限(CB)81%)。假设患病率为15%,培养基I的培养试验敏感性增益至少为18%(95%置信区间下限 - 4%),培养基II为40%(95%置信区间下限21%),培养基III为23%(95%置信区间下限2%)。

结论

已发表的直接毒素A/B EIA高达96%的高敏感性及其估计所假定的细胞毒性试验的正确性值得怀疑。使用培养基II,可获得至少约20%的敏感性增益。单独的直接毒素A/B EIA对艰难梭菌感染的临床诊断敏感性不足。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验